Scientific research
Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.
The findings of a news study reveal how Bifidobacterium evolve and adapt to different hosts, paving the way for targeted therapies such as customized probiotics and diet-based interventions.
CORAL can sample the microbes residing in upper gut in a non-invasive and reliable way, offering a tool for studying the diversity of the microbiota.
Profiling the human gut microbiota at the subspecies level, rather than at the species- or strain-level, provides more reproducible insights into how specific bacteria influence health and disease.
The findings of a recent study reveal a key strategy used by A. baumannii to colonize the gut and persist in it, highlighting a potential target for preventing its spread…
Prebiotic EN positively influenced certain gut bacteria, including Lactobacillus rhamnosus and Faecalicatena gnavus, and antibiotic resistance gene expression.
Even small differences between strains of gut bacteria—often within the same species—can sway how these microbes interact with the human body and influence disease outcomes.
A microbiota-mediated macrophage-dependent mechanism may be used to reduce diabetes incidence in vivo.
Altered gut bacteria may contribute to fibromyalgia and modifying the gut microbiota could offer a promising approach to reduce symptoms of the condition.
A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.
